Factor Xa-factor Va complex assembles in two dimensions with unexpectedly high affinity: an experimental and theoretical approach.
Safety and efficacy of anti-human activated protein C antibody SR604 for prophylaxis of congenital factor deficiencies.
Blocking human protein C anticoagulant activity improves clotting defects of hemophilia mice expressing human protein C.
Selective inhibition of activated protein C anticoagulant activity protects against hemophilic arthropathy.
